logo-loader
NASDAQ:AVXL

Anavex Life Sciences

Receive alerts
Market:
NASDAQ
Market Cap:
$276.9 m
Price
4.72 USD
Change
-7.27%
52 weeks high
6.30
52 weeks low
2.10

In brief

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.